An exploratory study on the role of high plasma HSP90α level is a risk factor for postoperative recurrence and overall survival in patient with hepatocellular carcinoma

Read full text Summarise with VIRAT
Authors: Wene Wei, Shirong Li, Jinglei Huang, Haizhou Liu, Litu Zhang
Cited by: 0
References: 48

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background The emerging plasma heat shock protein 90α (HSP90α) has good diagnostic value in hepatocellular carcinoma (HCC), but the prognosis was unclear. Aim of this study was to conduct an exploratory assessment of the prognostic value of plasma HSP90α in the HCC patients underwent hepatectomy. Methods 422 HCC hepatectomy patients were included. The optimal cutoff value was determined by using X-tile software. Survival analysis endpoints were recurrence-free survival (RFS) and overall survival (OS). Results The median of preoperative HSP90α and postoperative HSP90α levels were 80.40 ng/ml and 56.6 ng/ml, respectively. HCC hepatectomy patients with preoperative HSP90α < 202.0 ng/ml and HSP90α < 132.3 ng/ml showed a longer RFS and OS relative to those with higher preoperative HSP90α levels (3.5 vs. 1.9 months, p < 0.001; 23.7 vs. 20.1 months, p < 0.001; respectively). HCC hepatectomy patients with postoperative HSP90α < 56.0 ng/ml and HSP90α < 126.0 ng/ml showed a longer RFS and OS relative to those with higher postoperative HSP90α levels (2.5 vs. 2.3 months, p < 0.01; 22.7 vs. 20.9 months, p < 0.01; respectively). Patients with an HSP90α increase greater than 190% had worse RFS and OS and decline greater than 78% had worse OS after hepatectomy. In those HCC patients with AFP≥400 ng/ml, both preoperative and postoperative HSP90α were significantly correlated with RFS and OS (all p < 0.001). In those HCC patients with AFP

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Heat shock proteins research Lung Cancer Research Studies

Publication details

Journal / source
Heliyon
Volume
12
Issue
6
Pages
e44826–e44826
Publication date
26 March 2026
Language
EN